Índice

• • ·Editorial Board

    Página :i

    

• Reviews

  • ·Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes

    Página :179-190

    A.J. Scheen, N. Paquot

    Resumen Resumen Esquema Esquema  
  • ·Incretin dysfunction in type 2 diabetes: Clinical impact and future perspectives

    Página :195-201

    B. Ahrén

    Resumen Resumen Esquema Esquema

• Guidelines/Recommendations

  • ·Physical activity and type 2 diabetes. Recommandations of the SFD (Francophone Diabetes Society) diabetes and physical activity working group

    Página :205-216

    M. Duclos, J.-M. Oppert, B. Verges, V. Coliche, J.-F. Gautier, Y. Guezennec, G. Reach, G. Strauch, SFD diabetes and physical activity working group

    Resumen Resumen Esquema Esquema

• Original articles

  • ·Impact of objectively measured sedentary behaviour on changes in insulin resistance and secretion over 3 years in the RISC study: Interaction with weight gain

    Página :217-225

    E. Lahjibi, B. Heude, J.M. Dekker, K. Højlund, M. Laville, J. Nolan, J.-M. Oppert, B. Balkau, the RISC Study Group

    Resumen Resumen Esquema Esquema   
  • ·A model of poorly controlled type 1 diabetes mellitus and its treatment with aerobic exercise training

    Página :226-235

    C.W.J. Melling, K.N. Grisé, C.P. Hasilo, B. Fier, K.J. Milne, M. Karmazyn, E.G. Noble

    Resumen Resumen Esquema Esquema  
  • ·The METABOLIC Study: Multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment

    Página :236-243

    S. Maggi, M. Noale, A. Pilotto, A. Tiengo, P. Cavallo Perin, G. Crepaldi, for the Metabolic Working Group

    Resumen Resumen Esquema Esquema
  • ·Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes

    Página :244-249

    H. Wilmot-Roussel, D.-J. Lévy, C. Carette, S. Caillat-Zucman, C. Boitard, J. Timsit, D. Dubois-Laforgue

    Resumen Resumen Esquema Esquema  
  • ·Difficulty adhering to antidiabetic treatment: Factors associated with persistence and compliance

    Página :250-257

    L. Guénette, J. Moisan, M.-C. Breton, C. Sirois, J.-P. Grégoire

    Resumen Resumen Esquema Esquema
  • ·Accuracy assessment of online glucose monitoring by a subcutaneous enzymatic glucose sensor during exercise in patients with type 1 diabetes treated by continuous subcutaneous insulin infusion

    Página :258-262

    R.-P. Radermecker, C. Fayolle, J.-F. Brun, J. Bringer, E. Renard

    Resumen Resumen Esquema Esquema  
  • ·Allelic variations of the vitamin D receptor (VDR) gene are associated with increased risk of coronary artery disease in type 2 diabetics: The DIABHYCAR prospective study

    Página :263-270

    D.A.F. Ferrarezi, N. Bellili-Muñoz, D. Dubois-Laforgue, N. Cheurfa, A. Lamri, A.F. Reis, C. Le Feuvre, R. Roussel, F. Fumeron, J. Timsit, M. Marre, G. Velho

    Resumen Resumen Esquema Esquema  
  • ·High prevalence of undiagnosed diabetes and high risk for diabetes using HbA_1c criteria in middle-aged patients undergoing cataract surgery

    Página :271-275

    S. Feldman-Billard, N. Sedira, P.-Y. Boelle, F. Poisson, E. Héron

    Resumen Resumen Esquema Esquema  

• Short reports

  • ·Transcription factor gene MNX1 is a novel cause of permanent neonatal diabetes in a consanguineous family

    Página :276-280

    A. Bonnefond, E. Vaillant, J. Philippe, B. Skrobek, S. Lobbens, L. Yengo, M. Huyvaert, H. Cavé, K. Busiah, R. Scharfmann, M. Polak, M. Abdul-Rasoul, P. Froguel, M. Vaxillaire

    Resumen Resumen Esquema Esquema   
  • ·SLC29A3 mutation in a patient with syndromic diabetes with features of pigmented hypertrichotic dermatosis with insulin-dependent diabetes, H syndrome and Faisalabad histiocytosis

    Página :281-285

    J. de Jesus, Z. Imane, V. Senée, S. Romero, P.-J. Guillausseau, A. Balafrej, C. Julier

    Resumen Resumen Esquema Esquema